Anticancer activity of 1, 25-(OH)2D3 against human breast cancer cell lines by targeting Ras/MEK/ERK pathway

Anticancer activity of 1, 25-(OH)2D3 against human breast cancer cell lines by targeting Ras/MEK/ERK pathway

Wei Zheng,1 Lin Cao,2 Linna Ouyang,1 Qian Zhang,3 Bofeng Duan,1 Wei Zhou,4 Shan Chen,5 Wei Peng,1 Yi Xie,1 Qing Fan,6 Daoxing Gong7 1Department of Thyroid and Breast Surgery, The Third People’s Hospital of Shenzhen, Shenzhen, Guangdong 518112, China; 2Department of Breast Surgery, Maternal...

Full description

Bibliographic Details
Main Authors: Zheng W, Cao L, Ouyang L, Zhang Q, Duan B, Zhou W, Chen S, Peng W, Xie Y, Fan Q, Gong D
Format: Article
Language:English
Published: Dove Medical Press 2019-01-01
Series:OncoTargets and Therapy
Subjects:
breast cancer
1
25(OH)2D3
ER-negative
Ras/MEK/ERK
Online Access:https://www.dovepress.com/anticancer-activity-of-1-25-oh2d3-against-human-breast-cancer-cell-lin-peer-reviewed-article-OTT

Internet

https://www.dovepress.com/anticancer-activity-of-1-25-oh2d3-against-human-breast-cancer-cell-lin-peer-reviewed-article-OTT

Similar Items